115 related articles for article (PubMed ID: 19747030)
1. Are there unintended consequences of step-therapy programs?
Cox ER; Seiz BJ
Am J Manag Care; 2009 Sep; 15(9):654, 656; author reply 656. PubMed ID: 19747030
[No Abstract] [Full Text] [Related]
2. [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension].
Willenheimer R; Nyström F; Berggren B; Lindström T; Cizinsky S; Weiss L
Lakartidningen; 2008 Oct 22-28; 105(43):3055-6. PubMed ID: 19024623
[No Abstract] [Full Text] [Related]
3. First-line drugs for hypertension.
Spence JD
CMAJ; 2001 Jan; 164(2):176-8. PubMed ID: 11332306
[No Abstract] [Full Text] [Related]
4. The effects of antihypertensive step-therapy protocols on pharmaceutical and medical utilization and expenditures.
Mark TL; Gibson TB; McGuigan KA
Am J Manag Care; 2009 Feb; 15(2):123-31. PubMed ID: 19284809
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin receptor blockers: impact on costs of care.
Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
[TBL] [Abstract][Full Text] [Related]
6. [The pharmaco-economics of the treatment of arterial hypertension: data and controversies].
Rorive G; Delporte JP
Bull Mem Acad R Med Belg; 1998; 153(7-9):317-21; discussion 322-4. PubMed ID: 10100395
[TBL] [Abstract][Full Text] [Related]
7. [Medical economics of antihypertensive agents].
Yamazaki T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():285-8. PubMed ID: 16981557
[No Abstract] [Full Text] [Related]
8. Compliance with antihypertensive therapy: raising the bar of expectations.
Rudd P
Am J Manag Care; 1998 Jul; 4(7):957-66. PubMed ID: 10181995
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacotherapy of hypertension. How much can safely be saved?].
Anlauf M
MMW Fortschr Med; 2004 Apr; 146(15):57-8. PubMed ID: 15373022
[No Abstract] [Full Text] [Related]
10. Is newer always better? Re-evaluating the benefits of newer pharmaceuticals.
Law MR; Grépin KA
J Health Econ; 2010 Sep; 29(5):743-50. PubMed ID: 20656362
[TBL] [Abstract][Full Text] [Related]
11. [Comment on IOWiG report plan. A medical decision may not be replaced].
Vorstand der Deutschen Hochdruckliga E.V
MMW Fortschr Med; 2006 May; 148(19):42. PubMed ID: 16736705
[No Abstract] [Full Text] [Related]
12. Cost of hypertension treatment and the price of health.
Menard J; Cornu P; Day M
J Hum Hypertens; 1992 Dec; 6(6):447-58. PubMed ID: 1296008
[No Abstract] [Full Text] [Related]
13. [Health care too costly? Saving more than 10 million euros in 2 months!].
Rappert B
MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
[No Abstract] [Full Text] [Related]
14. [Pharmacoeconomic aspects of the treatment of essential hypertension].
Martynov AI; Giliarevskiĭ SR; Ostroumova OD; Nesterova MV; Mamaev VI
Ter Arkh; 2001; 73(9):82-8. PubMed ID: 11642090
[No Abstract] [Full Text] [Related]
15. Relative costs of antihypertensive drug treatment.
Strasser T
J Hum Hypertens; 1992 Dec; 6(6):489-94. PubMed ID: 1296015
[No Abstract] [Full Text] [Related]
16. [Real and assumed potential savings in antihypertensive treatment. Right out of the magician's hat].
Anlauf M; Hense HW
Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1557-9. PubMed ID: 12854069
[No Abstract] [Full Text] [Related]
17. Evaluation of the total cost of treating elderly hypertensive patients with ACE inhibitors: a comparison of older and newer agents.
Small RE; Freeman-Arnold SB; Goode JV; Pyles MA
Pharmacotherapy; 1997; 17(5):1011-6. PubMed ID: 9324190
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Caro JJ; Lee K
Curr Hypertens Rep; 2002 Dec; 4(6):417-8. PubMed ID: 12419166
[No Abstract] [Full Text] [Related]
19. NIH promotes use of lower cost drugs for hypertension.
Spurgeon D
BMJ; 2004 Mar; 328(7439):539. PubMed ID: 15001483
[No Abstract] [Full Text] [Related]
20. Health economic issues and the future treatment and management of hypertension.
Giles TD
AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
